Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TLR2 | O60603 | 12/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14012316 | 0.85 | MEN1 (0.50) | MEN1KMT2ATLR2CA2 | |
| SCHEMBL29430501 | 0.84 | MEN1 (0.49) | MEN1KMT2ATLR2CA2S1PR1 | |
| SCHEMBL18089443 | 0.84 | MEN1 (0.49) | MEN1KMT2ATLR2CA2DPP7 | |
| SCHEMBL23158601 | 0.83 | MEN1 (0.47) | MEN1KMT2ATLR2CA2DPP7 | |
| SCHEMBL7298639 | 0.83 | MEN1 (0.51) | MEN1KMT2ATLR2USP2TSHR | |
| SCHEMBL15503581 | 0.82 | MEN1 (0.47) | MEN1KMT2ATLR2CA2DPP7 | |
| SCHEMBL25708285 | 0.81 | MEN1 (0.46) | MEN1KMT2ATLR2TSHRCA2 | |
| SCHEMBL13566444 | 0.81 | CA2 (0.50) | MEN1KMT2ATLR2CA2DPP7 | |
| SCHEMBL12266591 | 0.81 | CA2 (0.50) | MEN1KMT2ATLR2CA2DPP7 | |
| SCHEMBL7300946 | 0.81 | MEN1 (0.58) | MEN1KMT2ATLR2CA2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114173824-A | Antibody drug conjugates | 武田药品工业株式会社 | 2022-03-11 | — | — | CN | disclosed |